Nalaganje...

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

BACKGROUND: The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (BCa) was established primarily with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), with complete response rates (pT0) as high as 38%. However, because of the comparable efficacy with better...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Zargar, Homayoun, Espiritu, Patrick N., Fairey, Adrian S., Mertens, Laura S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobsen, Niels-Erik, Gandhi, Nilay, Griffin, Joshua, Montgomery, Jeffrey S., Vasdev, Nikhil, Yu, Evan Y., Youssef, David, Xylinas, Evanguelos, Campain, Nicholas J., Kassouf, Wassim, Dall’Era, Marc A., Seah, Jo-An, Ercole, Cesar E., Horenblas, Simon, Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M., Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., van Rhijn, Bas W., Daneshmand, Siamak, Spiess, Philippe E., Black, Peter C.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840190/
https://ncbi.nlm.nih.gov/pubmed/25257030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.09.007
Oznake: Označite
Brez oznak, prvi označite!